Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125632481 | 12563248 | 1 | I | 20160106 | 20160223 | 20160715 | 20160715 | EXP | GB-ALLERGAN-1635638US | ALLERGAN | 50.00 | YR | F | Y | 64.00000 | KG | 20160715 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125632481 | 12563248 | 1 | PS | BOTOX | ONABOTULINUMTOXINA | 1 | Parenteral | UNK, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 125632481 | 12563248 | 2 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | 103000 | POWDER FOR INJECTION | |||||||||||
| 125632481 | 12563248 | 3 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | 103000 | POWDER FOR INJECTION | |||||||||||
| 125632481 | 12563248 | 4 | C | CALCICHEW D3 | CALCIUMCHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 125632481 | 12563248 | 5 | C | DIAZEPAM. | DIAZEPAM | 1 | U | 0 | |||||||||||
| 125632481 | 12563248 | 6 | C | DOCUSATE | DOCUSATE | 1 | U | 0 | |||||||||||
| 125632481 | 12563248 | 7 | C | OXYCODONE | OXYCODONE | 1 | U | 0 | |||||||||||
| 125632481 | 12563248 | 8 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | U | 0 | |||||||||||
| 125632481 | 12563248 | 9 | C | RESOLOR | PRUCALOPRIDE SUCCINATE | 1 | U | 0 | |||||||||||
| 125632481 | 12563248 | 10 | C | SALAGEN | PILOCARPINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125632481 | 12563248 | 11 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | U | 0 | |||||||||||
| 125632481 | 12563248 | 12 | C | STILNOCT | ZOLPIDEM TARTRATE | 1 | U | 0 | |||||||||||
| 125632481 | 12563248 | 13 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125632481 | 12563248 | 1 | Back pain |
| 125632481 | 12563248 | 2 | Myofascial pain syndrome |
| 125632481 | 12563248 | 3 | Pain |
| 125632481 | 12563248 | 4 | Product used for unknown indication |
| 125632481 | 12563248 | 5 | Product used for unknown indication |
| 125632481 | 12563248 | 6 | Product used for unknown indication |
| 125632481 | 12563248 | 7 | Product used for unknown indication |
| 125632481 | 12563248 | 8 | Product used for unknown indication |
| 125632481 | 12563248 | 9 | Product used for unknown indication |
| 125632481 | 12563248 | 10 | Product used for unknown indication |
| 125632481 | 12563248 | 11 | Product used for unknown indication |
| 125632481 | 12563248 | 12 | Product used for unknown indication |
| 125632481 | 12563248 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125632481 | 12563248 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125632481 | 12563248 | Incorrect route of drug administration | |
| 125632481 | 12563248 | Malaise | |
| 125632481 | 12563248 | Myositis | |
| 125632481 | 12563248 | Off label use | |
| 125632481 | 12563248 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125632481 | 12563248 | 1 | 20160106 | 20160106 | 0 |